Uranium Royalty Corp.
UROYEnergyNASDAQUranium
Scan Results
Daily timeframePart of the energy sector, Uranium Royalty Corp. (UROY) is listed under Uranium. The $1.69B market capitalization puts UROY squarely in small-cap range for its industry. It engages in acquiring and assembling a portfolio of royalties; investing in companies with exposure to uranium and physical uranium; and the purchase and sale of physical uranium.
Market Cap
$1.69B
Beta
1.42
P/E (TTM)
15.31
P/E (Fwd)
146.25
EPS (TTM)
$0.29
EPS (Fwd)
$0.03
ROE
15.3%
ROA
10.7%
Cash
$254.3M
Total Debt
$114,000
Free CF
$169.6M
52W Change
38.3%
Annual Financials
Cash vs Debt
Where UROY stands vs its 150-day and 200-day moving averages
As of the September 1, 2026 close, UROY finished 15.34% above its 150-day moving average ($3.65) and 13.78% above its 200-day moving average ($3.70). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is UROY overbought or oversold?
At the September 1, 2026 close, UROY's RSI(14) was 51.7, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $254.3M in cash comfortably exceeding the $114K debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $169.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 15.2%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 10.7% further supports the picture of efficient asset utilization. Revenue has grown from $10.1M (2023) to $187.0M (2026), reflecting a 1743% increase over the period.
With cash comfortably exceeding debt, UROY has financial flexibility that may help navigate uncertain periods. No single metric tells the full story. Reviewing UROY's risk profile alongside its fundamentals and technical indicators provides a more complete picture.